This document discusses medical technology innovations and value merging services. It introduces ValueMerge, which helps innovative small and medium enterprises (SMEs) in healthcare merge their unique value propositions. ValueMerge provides business catalyzing, coordination, marketing applications, and training services to help SMEs penetrate new markets like Turkey. The services help SMEs progress through phases from pre-research to rollout and operations. The document outlines ValueMerge's experience and knowledge in areas like medical imaging, hybrid operating rooms, and software solutions. It provides examples of reference projects coordinated by ValueMerge in Turkey.
This short presentation describes the capabilities of Value Vision Consulting, an International Management consultancy dedicated to the biopharma innovation valuing and market access.
Case Studies presented at EMIG - Introduction to ilSilsintelligence
ilS presented a series of cases in order to demonstrate the ways ilS has been able to guide intelligent decision making of companies in the sector at the EMIG Business Development meeting in Oxfordshire (20th June 2013)
This short presentation describes the capabilities of Value Vision Consulting, an International Management consultancy dedicated to the biopharma innovation valuing and market access.
Case Studies presented at EMIG - Introduction to ilSilsintelligence
ilS presented a series of cases in order to demonstrate the ways ilS has been able to guide intelligent decision making of companies in the sector at the EMIG Business Development meeting in Oxfordshire (20th June 2013)
Passion for cross-industry R&D and innovation, design thinking, challenging assumptions, identifying problems and providing alternative strategy and solutions. Curious about "new" domain, love learning and evaluating new disruptive trends, effective communicator, team player and flexible with a great sense of humour.
Summarize the end of 2015, QYR is very hard, and the results were very good, positive, and believe in 2016 will be more exciting because we enjoy working hard
ttopstart academy: how to write a successful ERC PoC proposalttopstart B.V.
The ERC Proof of Concept (PoC) grant is an excellent opportunity for ERC laureates to assess the commercial feasibility of promising research outcomes. This presentation covers some key best practices to make sure you successfully acquire the grant.
Presentation of CRAASH Barcelona, the new project of Biocat (Moebio Barcelona). The initiative is a 12-week program that helps European research teams launch successful device, diagnostic and e-/digital health innovations to improve health and patient care.
BIS (Business Intelligence and Strategy) Research ProfileBIS Research
BIS Research is a global cutting edge technology research and advisory company which focuses on those emerging trends in technology which are likely to disrupt the dynamics of the market.
BIS Research publishes in-depth global market intelligence reports across different industry verticals-Electronics, Semiconductor, Telecom, Information Technology, Automotive, and Medical Devices among other emerging technologies.
Innovation and the Evolution of the New Customer ModelDoblin Inc.
How to rethink the customer model of healthcare and innovate the pharma industry in the process. Jeff Wordham and Kathleen Onieal of Doblin/Monitor outline common obstacles to innovation--and ways to overcome them. (Presented at the ePharma conference in New York in February 2011.)
Planning and Executing the Product Development and Manufacture of Medical De...MaRS Discovery District
This interactive presentation will provide answers to common questions that medtech startups struggle with, such as:
What is an ISO-13485-compliant QMS and can you develop a medical device without one?
How much does it really cost to transfer a medical device into manufacturing?
How do you drive alignment between the core technology and the design and business architectures during the product development process?
How do you communicate your technology readiness to investors?
The Changing Pharma R&D Model, GDDIS Leaders Summit Ted Torphy CSO, Head, External Innovation Research Excellence, Advance Technologies Janssen R&D
A Johnson & Johnson Pharmaceutical Company
Previous Position
www.gbx.uk.com
www.gddis.com
www.gddif.com
www.wddis.com
Technology Transfer in Pharma Industry, Technology Transfer in Pharmaceutical Industry, Pharmaceutical Technology Transfer, Pharma Tech Transfer, Naseeb basha, Pharmaceutical Tech Transfer, Naseeb basha Technology Transfer in Pharma Industry, Naseeb basha Pharmaceutical Technology Transfer
Passion for cross-industry R&D and innovation, design thinking, challenging assumptions, identifying problems and providing alternative strategy and solutions. Curious about "new" domain, love learning and evaluating new disruptive trends, effective communicator, team player and flexible with a great sense of humour.
Summarize the end of 2015, QYR is very hard, and the results were very good, positive, and believe in 2016 will be more exciting because we enjoy working hard
ttopstart academy: how to write a successful ERC PoC proposalttopstart B.V.
The ERC Proof of Concept (PoC) grant is an excellent opportunity for ERC laureates to assess the commercial feasibility of promising research outcomes. This presentation covers some key best practices to make sure you successfully acquire the grant.
Presentation of CRAASH Barcelona, the new project of Biocat (Moebio Barcelona). The initiative is a 12-week program that helps European research teams launch successful device, diagnostic and e-/digital health innovations to improve health and patient care.
BIS (Business Intelligence and Strategy) Research ProfileBIS Research
BIS Research is a global cutting edge technology research and advisory company which focuses on those emerging trends in technology which are likely to disrupt the dynamics of the market.
BIS Research publishes in-depth global market intelligence reports across different industry verticals-Electronics, Semiconductor, Telecom, Information Technology, Automotive, and Medical Devices among other emerging technologies.
Innovation and the Evolution of the New Customer ModelDoblin Inc.
How to rethink the customer model of healthcare and innovate the pharma industry in the process. Jeff Wordham and Kathleen Onieal of Doblin/Monitor outline common obstacles to innovation--and ways to overcome them. (Presented at the ePharma conference in New York in February 2011.)
Planning and Executing the Product Development and Manufacture of Medical De...MaRS Discovery District
This interactive presentation will provide answers to common questions that medtech startups struggle with, such as:
What is an ISO-13485-compliant QMS and can you develop a medical device without one?
How much does it really cost to transfer a medical device into manufacturing?
How do you drive alignment between the core technology and the design and business architectures during the product development process?
How do you communicate your technology readiness to investors?
The Changing Pharma R&D Model, GDDIS Leaders Summit Ted Torphy CSO, Head, External Innovation Research Excellence, Advance Technologies Janssen R&D
A Johnson & Johnson Pharmaceutical Company
Previous Position
www.gbx.uk.com
www.gddis.com
www.gddif.com
www.wddis.com
Technology Transfer in Pharma Industry, Technology Transfer in Pharmaceutical Industry, Pharmaceutical Technology Transfer, Pharma Tech Transfer, Naseeb basha, Pharmaceutical Tech Transfer, Naseeb basha Technology Transfer in Pharma Industry, Naseeb basha Pharmaceutical Technology Transfer
This presentation provides overview about our offerings under the Market Intelligence Services category. It mainly shows what we have done and what we can do in terms of studying and assessing the opportunities in new markets / products.
Executive Healthcare Seminar - Belgium - Saudi Arabia - Belgian Embassy RiyadhJan Demey
Belgian and Saudi Healthcare executives met in the Belgian Embassy to discuss several topics in the evolving healthcare market and the Vision 2030 of the Kingdom of Saudi Arabia. The ambition to work together to make healthcare better is our joined ambition. This presentation brings the supporting ideas as discussed during the seminar.
Medtech.Capabilities.Frost & Sullivan.2009Siddharth Singh
Frost & Sullivan is a growth consulting company. The "Healthcare Practices" focuses on identifying emerging opportunities in Medical Devices industry and offer various market strategies.
2. 2
Vision
Medical Technologies in the future will be pioneerd by the ‘Open Innovations’ of
Small Medium Enterprises
in modular form
Technical
Perspectives
Commercial
Perspectives
Clinical
Perspectives
2
3. 3
Value Match is not enough between
Clinical & Technical & Commercial Perspectives;
You need the
3
4. 4
SERVICES
Business
Catalyzing &
Coordination
Marketing
Applications
Implementations &
Training & Workshops
S
e
r
v
i
c
e
s
In Medical
Technologies
Focus
Innovative SME’s (Small Medium Enterprise’s) in
Healthcare
Relevant/side sector companies of Healthcare
Clinical & Technical Research Institutions
4
5. 5
Business
Catalyzing &
Coordination
S
e
r
v
i
c
e
s
In Medical
Technologies
Business Model Innovations
New Markets
Multidimensional Open Innovations
Elegant Business Networking
5
6. 6
Marketing
Applications
S
e
r
v
i
c
e
s
In Medical
Technologies
Specific Value Proposition
Unique Value Innovation
Match & Merge
6
7. Hand-Over to Operational Marketing & Sales
7
Implementations &
Training & Workshops
S
e
r
v
i
c
e
s
In Medical
Technologies
Intercultural ValueMerge in Business
Clinical Applications
7
8. Business Catalyzing & Coordination
in Open Innovations
8
Healthcare
Needs
&
Requests
in
TR
Matched &
Merged with
Unique
Value
Proposition
SME 1
SME 2
Pilot
Academic
Hospital(s) TR
Value
Merge
Sales &
Operations
based SME(s)
TR
Academic
Hospital(s)
Europe
Value
Merge
Private
Hospital(s)
TR
Value
Merge
Value
Merge
Value
Merge
Value
Merge
Investor
TR
Investor
and/or Europe
Grant
and/or
8
9. Business Catalyzing & Coordination
in Open Innovations
9
Healthcare
Needs
&
Requests
in
TR
Matched &
Merged with
Unique
Value
Proposition
SME 1
SME 2
Academic
Hospital(s) TR
Value
Merge
Sales &
Operations
based SME(s)
TR
Public
Hospital(s)
TR
Value
Merge
Innovative, Simplified, Effective
Multidisciplinary Tailormade Healthcare
Services
Value
Merge
Value
Merge
Value
Merge
Value
Merge
Private
Hospital(s)
TR
9
10. Steps to the
Turkish Market
10
Phases Questions & Actions Content Action Holders Duration
Phase 1
Pre-Research
Who?
Involved stakeholders in the
project phases; target group
profiles; competitors ValueMerge &
SME
4 – 6 weeks
(Total 30
hours
charged
consultancy)
What? Clinical applications
Why?
Clinical, technical and commercial
values; facts from the market
Phase 2
Introduction Trip to Turkey
How?
When?
How much?
Interactieve discussions with the
basic profile groups of the
stakeholders in Turkey
Interviewing to verify the Business
& Marketing Plan inputs
ValueMerge &
SME 3 - 5 days
Evaluation Go / No Go
Decision making regarding the
market penetration in Turkey
according to the collaboration
strategy , impressions and the
gathered information from the
market
ValueMerge &
SME(s) & Local
Partner(s)
`
…
Phase 3
Planning &
Implementation Period
Benchmarking
• Marketing plan
• PR plan
• Project plan
• Business plan
• Implementation plan
ValueMerge &
SME(s)
6-12 months
(30 hours
per month
charged
consultancy)
Phase 4
Rollout
Operations SME’s service becomes settled &
operational in Turkish market
ValueMerge &
SME(s) & Local
Partner(s)
12 - 36
months
10
11. 11
Know How
• Business & Project Coordination in Turkey in medical technologies
• “First-of-Kind” Value Proposition House creation for Surgery Mobile X-Ray imaging systems
• Worldwide (In USA, UK, Ireland, The Netherlands, Germany, France, Italy, Spain, Greece, Japan,
Singapore, Thailand etc.) Modular Training Programs for Surgery X-Ray imaging systems
• Worldwide Leadership of Image Quality Team for Surgery Mobile X-Ray systems
• General Application Management of HybOR (Hybrid Operating Room) solutions
• Sterilization Analysis of Hybrid Operating Rooms and the preparation of “First-of-Kind” HybOR
Cleaning Protocols
11
12. 12
Know How (cont.)
• Applications of the “First-of-Kind” Flexible Movement solution for the ceiling
mounted X-ray imaging system in Hybrid Operating room
• “First-of-Kind” Integration Applications of the ceiling mounted X-Ray system and
stand alone operating table
• Global Marketing for (X-Ray, MR, CT, US based) Quantitative SW analysis solutions
• Regional Marketing for (Turkey & Israel) CT, MR, PACS, RIS solutions
• R&D Experience in Telecommunication as “First-of-Kind” SW Production
Environment Preparation and Activation in Turkey
12
14. 14
Referance Projects
BMA Project Coordination in Turkey (on going)
Teledyne DALSA Professional Imaging Management Consultancy Workshop (completed)
MobiHealth Business Coordination in
Turkey (handed over in Phase 3)
Machnet Business Coordination in
Turkey (handed over in Phase 4)
14